Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

33.61
+0.42001.27%
Volume:82.53K
Turnover:2.77M
Market Cap:2.35B
PE:-10.70
High:34.05
Open:33.28
Low:33.05
Close:33.19
52wk High:34.41
52wk Low:16.72
Shares:69.86M
Float Shares:39.06M
Volume Ratio:1.20
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1416
EPS(LYR):-3.4871
ROE:-73.02%
ROA:-42.31%
PB:8.76
PE(LYR):-9.64

Loading ...

Pharvaris CMO Lu Peng disposes of 300 shares worth $10,200

Reuters
·
18 hours ago

Pharvaris (PHVS) Is Up 6.0% After Strong Phase 3 Oral HAE Data With Novel Endpoint Introduction

Simply Wall St.
·
Jun 19

Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Pharvaris (PHVS)

TIPRANKS
·
Jun 16

Pharvaris says Phase 3 RAPIDe-3 trial shows oral deucrictibant cuts median HAE symptom relief time to 1.28 hours

Reuters
·
Jun 15

Pharvaris publishes patient-reported outcomes presentation on clinical evidence in HAE trials

Reuters
·
Jun 12

Pharvaris announces annual shareholder meeting

Reuters
·
Jun 11

A Look At Pharvaris (PHVS) Valuation As Deucrictibant Data Advances Toward Key EAACI 2026 Catalyst

Simply Wall St.
·
Jun 07

The Bull Case For Pharvaris (PHVS) Could Change Following New Deucrictibant Phase 3 Data Disclosures

Simply Wall St.
·
May 31

Pharvaris to present Phase 3 RAPIDe-3 end-of-progression data for oral deucrictibant in hereditary angioedema at EAACI 2026

Reuters
·
May 29

Pharvaris Principal Accounting Officer Anna Nijdam disposes of common shares worth $224,207.69

Reuters
·
May 27

Pharvaris director Elisabeth Bjork disposes 10,000 common shares for $293,166

Reuters
·
May 23

Pharvaris Chief Commercial Officer Wim Souverijns sells 10,000 shares for $299,163

Reuters
·
May 20

Pharvaris price target raised to $33 from $31 at BofA

TIPRANKS
·
May 15

Pharvaris (PHVS) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pharvaris (PHVS) and Allogene Therapeutics (ALLO)

TIPRANKS
·
May 14

Stock Track | Pharvaris N.V. Soars 5.09% Intraday on Bullish Analyst Ratings

Stock Track
·
May 14

Pharvaris Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 13

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (STXS)

TIPRANKS
·
May 13

RBC Capital Reaffirms Their Buy Rating on Pharvaris (PHVS)

TIPRANKS
·
May 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13